News Jul 06, 2022 Qarad, part of the QbD Group, expands to Switzerland Belgian-based IVD specialist Qarad is your gateway to Europe for In Vitro Diagnostics and Medical Devices. The company has recently opened a new ...
Analysis Mar 22, 2021 B2B Digital Marketing in China The digital landscape in China is unique and fast-evolving, way different than in Europe. In order to find out how the Swiss companies in China a...
News Nov 30, 2021 Hemex banks 7.1 million Swiss francs Hemex has raised a total of 7.1 million Swiss francs as part of a Series C financing round. The company for clinical contract research and invest...
News Nov 10, 2021 Geistlich Pharma’s collagen membrane authorized for use in the USA The Geistlich Nexo-Gide has obtained clearance from the US Food and Drug Administration (FDA). The collagen membrane developed by Geistlich Pharm...
News Feb 09, 2021 Pharmaceutical and biotech expert ZETA opens a new subsidiary in the canton of Valais ZETA, an Austrian engineering specialist for the pharmaceutical and biotech industries, has recently opened a subsidiary in Visp, with the aim of...
News May 18, 2021 Biopôle’s new “Start-Up Fund” aims to promote early access to innovation in the life sciences Biopôle has announced the launch of the “Biopôle Start-Up Fund”, a new fund dedicated to supporting the next generation of impact-driven life sci...
News May 11, 2021 EPFL spin-off bNovate expands globally after raising CHF 5 million With its connected solutions allowing bacteria measurement in water in only 20 minutes, industrial microbiology specialist bNovate Technologies h...
News Mar 08, 2021 Debiopharm enters EUR 900+ million contract with Merck Debiopharm has granted a worldwide exclusive license to pharma giant Merck for the development and commercialization of its Xevinapant head and n...
Third Party Event Webinar COVID-19: Challenges and Opportunities in Brazil and Mexico for Swiss Business